Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page

Shivam Puri, Managing Director and CEO of Cipla Health Ltd, to serve on the Grand Jury for IMA 2025, as reported by Exchange4Media.

by Team Small News | Oct 4, 2025 | Cipla, Pharma

The Indian Media Awards (IMA) 2025 Grand Jury consists of esteemed industry professionals, including Shivam Puri, Managing Director & CEO of Cipla Health Ltd. As reported by Exchange4Media, the IMA 2025 aims to recognize and celebrate excellence in the media...
Dr Sharvil Patel of Zydus Lifesciences assumes the role of President at the Indian Pharmaceutical Association

Dr Sharvil Patel of Zydus Lifesciences assumes the role of President at the Indian Pharmaceutical Association

by Team Small News | Oct 3, 2025 | Cipla, Pharma, Sun Pharma, Zydus

Zydus Lifesciences’ Managing Director, Dr. Sharvil Patel, has taken over as the new President of the Indian Pharmaceutical Alliance (IPA). The IPA is a coalition of Indian pharmaceutical companies that aims to promote the interests of the domestic pharmaceutical...
China’s reduction in import duties helps alleviate the impact of US tariffs on India’s pharmaceutical industry.

China’s reduction in import duties helps alleviate the impact of US tariffs on India’s pharmaceutical industry.

by Team Small News | Sep 29, 2025 | Aurobindo Pharma, Cipla, Lupin, Pharma, Sun Pharma

The Indian pharmaceutical industry is facing a complex global trade landscape, with contrasting developments in China and the US. China has reduced import duties on Indian pharma products by 30%, effectively enabling near-zero-cost access, providing a significant...
China’s reduction in import duties helps alleviate the impact of US tariffs on India’s pharmaceutical industry.

Generic pharmaceutical companies dodge significant damage, avoiding a medical emergency.

by Team Small News | Sep 27, 2025 | Cipla, Pharma, Sun Pharma

India’s generic pharmaceutical companies are likely to continue business as usual despite US President Donald Trump’s 100% levy on pharmaceuticals. The tariff is targeted at branded and patented medicines, which may not directly impact generic companies....

Cipla Group company InvaGen Pharmaceuticals partners with Bora Biologics for production of NYPOZI at their San Diego facility.

by Team Small News | Sep 25, 2025 | Cipla, Pharma

Bora Biologics has partnered with InvaGen Pharmaceuticals, a subsidiary of Cipla Group, to manufacture NYPOZI(TM) at its San Diego facility. This partnership marks a significant milestone in the production of NYPOZI(TM), a crucial medication for patients in need. Bora...

Umang Vohra set to step down, with Achin Gupta poised to succeed as new Global CEO.

by Team Small News | Sep 23, 2025 | Cipla, Pharma

In a significant development, Cipla, a leading pharmaceutical company, is undergoing a leadership shift. Umang Vohra, the current Managing Director and Global Chief Executive Officer (CEO), has decided to exit the company. Vohra’s departure marks the end of an...
« Older Entries
Next Entries »

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress